↑ Business 'Stranger Things' ushered in a new era for Netflix - A lot has changed since its first season in 2016, as Netflix has announced dozens of "Stranger Things" partnerships and collaborations with brands.Oracle says there have been 'no delays' in OpenAI arrangement after stock slide - Oracle pushed back against a report that said the company will complete data centers for OpenAI, one of its major customers, in 2028, rather than 2027.Broadcom tumbles 11% despite blockbuster earnings as 'AI angst' weighs on Oracle, Nvidia - Even with better-than-expected earnings and revenue, Broadcom slid on Friday as investors continued to grow concerned about the AI trade.‘The next protein’: Fiber is shaping up to be the latest grocery obsession - As consumers find their next grocery obsession in fiber, food and beverage companies are racing to keep up with the trend.AI shopping could drive $263 billion in holiday sales. Walmart and Target are racing to get in - Consumers are turning to AI chatbots like ChatGPT for gift discovery, reviews and price matching, potentially driving billions in sales this holiday season.Oracle's lease commitments jump by almost 150% as company builds out to meet AI demand - Oracle's lease commitments now total $248 billion, with $10 billion tied to cloud capacity. Costco tops Wall Street's sales and revenue expectations - Costco on Thursday surpassed Wall Street's quarterly expectations as its sales rose 8.2% year over year.Broadcom beats on earnings and revenue, says AI chip sales will double in current quarter - Broadcom stock is near an all-time high and has climbed 75% so far in 2025.Rivian announces new AI tech, in-house chip and robotaxi ambitions - The company has also developed AI models to power its Autonomy+ subscription, which it intends to roll out early next year for $2,500 upfront or $49.99 a month.Eli Lilly's next-generation obesity drug delivers strong weight loss, reduces knee pain in late-stage trial - The drugmaker is betting big on retatrutide as the next pillar of its obesity portfolio after its weight loss injection Zepbound and its upcoming pill.